Innovative solutions to
keep your project on course

Modeling and Simulation

With modeling and simulation, your existing data can answer important questions and result in significant savings in future studies. Model-based drug development consists of the use of mathematical and statistical methods to:

  • understand how various dosing choices (e.g., dose, dose frequency, dosing duration) affect drug concentrations
  • clarify the relationship between drug concentration and desired or undesired pharmacodynamic responses
  • characterize the PK/PD variability of drugs and assist in understanding the clinically relevant factors contributing to variability

Nuventra has an expert team of pharmacometricians who build models to guide your future drug development decisions. Our team creates tailored model-based drug development plans, including rational selection of the most salient model for a given investigational compound and disease area.

Our Modeling and Simulation services:

Explore Our Blog

Renal Impairment

Is a Renal Impairment Study Needed for NDA or BLA Approval?

Common Questions and Answers Is a renal impairment study needed for your drug development program and NDA/BLA? The answer depends…

Read More
Pediatric drug development

Challenges in Pediatric Drug Development and Clinical Trials

Recently, the FDA released an update to the nearly two-decades old harmonized guidelines on clinical investigations in pediatric patients (originally…

Read More
Hepatic Impairment

How to Avoid a Hepatic Impairment Clinical Study During Drug Development

Is it possible to avoid a hepatic impairment clinical study during drug development? The short answer is ‘yes,’ by using…

Read More